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The unraveling of cellular mechanisms relies heavily on understanding protein-protein interactions (PPIs). For example, interactions between proteins play a crucial role in host-pathogen interactions and are therefore potential therapeutic targets. To better understand the role of protein interactions in diverse processes, more powerful techniques to identify and confirm interactors of membrane and membrane-associated proteins have to be developed.
The majority of identified PPIs have been found using the yeast two-hybrid ( Y2H) screen because it is a very powerful tool for identifying unknown interaction partners. A Y2H screen always yields a varying number of false-positive candidates. Therefore, results from Y2H screens must be confirmed by independent methods (1, 2) . Detecting protein complexes between two membrane proteins by co-immunoprecipitation is extremely difficult, if sometimes not impossible, due to their unstable interaction when being extracted from membranes. The most common technique used to circumvent this problem is to measure fluorescence (Förster) resonance energy transfer (FRET) between two fluorophores such as cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) fused to the interacting proteins. It is also possible to confirm PPIs with a proximity ligation assay (PLA) (3) .
In this study, we present an approach that combines the wellestablished FRET technique and the recently introduced PLA. Combining FRET with PLA analysis allows visualization of YFP-and CFP-tagged interacting proteins and therefore detects cells that are co-expressing interactors. FRET-PLA can be further used to locate PPIs with an increased sensitivity and with a high spatial resolution. Intensity-based FRET analyses have a lower signal-to-noise ratio than PLA analyses, which detect PPI as a bright fluorescent dot (4) (5) (6) . The introduction of the PLA technique during FRET measurements simultaneously allows an additional readout of PPIs based on recognition of epitopes that are in close proximity. By combining the advantages of the two methods, we were able to precisely determine the molecular proximity between two membrane proteins at nanometer distances.
Materials and methods

Molecular cloning
All primers used in the cloning steps (Supplementar y Table S1 ) were obtained from Sigma Aldrich (Steinheim, Germany), and an overview of the cloning strategy is displayed in Supplementar y Figure S2 . The CD63 sequence was amplified using P fuUltra HF polymerase (Agilent Technologies, Böblingen, Germany) from the Y2H vector pPR3-N-CD63 (containing the full-length human CD63 sequence, codons 1 to 238, Genebank accession no. KF998086) in the pCMV-Tag2B vector (Stratagene, Heidelberg, Germany) using the primer pair DI001/D002 (containing a 5´ BamHI linker and a 3´ HindIII linker). The amplicon was digested with the indicated restriction enzymes (New England Biolabs, Frankfurt, Germany) and was ligated with T4 DNA ligase (New England Biolabs) into the BamHI/HindIII digested vector pCMVTag2B. Likewise, the cDNA (gp160 of Investigation of membrane protein-protein interactions using correlative FRET-PLA Fluorescence resonance energy transfer (FRET) analysis and the recently developed proximity ligation assay (PLA) are widely used to study protein-protein interactions in situ. We have developed correlative FRET-PLA to monitor interactions between membrane proteins that frequently cause problems in confirmatory co-immunoprecipitation assays. Correlative FRET-PLA is particularly aimed at delivering robust and reliable results and is useful for investigating protein-protein interactions.
Reports
METHOD SUMMARY
We combined FRET and PLA techniques in order to investigate protein-protein interactions between membrane proteins. We then demonstrated that PLA strongly correlates with FRET values. An important feature of the combined FRET-PLA approach is the additional readout of high spatial resolution from the PLA signals. HIV-1, codons 534 to 709, Genbank accession no. AY669735.1) was cloned into the pcDNA4B-V5-His (Invitrogen, Karlsruhe, Germany) vector in between PstI/NotI restriction sites using primer pair DI003/DI004 and the pNL4-3 vector (AIDS Reference and Reagent Program, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD). To introduce the murine Ig kappa-chain V-J2-C (SP1), we used the primer pair DI005/DI006, the restriction sites NheI/ BamHI, and the vector pDisplay (Invitrogen). The CFP and YFP fragments were amplified using the primer pairs DI007/DI008 and DI009/DI010 flanked by XhoI/SacII and XhoI/ApaI restriction sites. The FRET negative control vectors pcDNA-CFP and pCMV-YFP were constructed using XhoI/ApaI restriction sites and the primer pairs DI011/DI012 and DI013/DI014. We use modified YFP/CFP sequences as templates derived from the vectors encoding pSCFP3A-C1 and pSYFP2-C1 (7). All constructs were verified by Sanger sequencing. The vector pECFP-EYFP was a gift from M. Schindler (8) , and the vector pZFN-YFP expressing a zinc finger nuclease against pol sequences of the porcine endogenous retroviruses was provided by M. Semaan.
Cell culture, transfection, and application of cells on glass slides Human embryonic kidney (HEK293T) cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (Biochrom AG, Berlin, Germany), 100 IU/mL penicillin, 100 µg/mL streptomycin (PAA Laboratories, Cölbe, Germany), and 2 mM l-glutamine (Biochrom AG). HEK293T (5 × 10 5 cells/well) were seeded in 6-well plates. After 5 h, cells were transiently transfected with 3 µg/well of each plasmid (FRET vectors pCMV-CD63-YFP-FLAG, pcDNA-gp41-CFP-V5, pCMV-YFP, pcDNA-CFP, and empty vectors pCMV-Tag2B/pcDNA4B-V5-His) using MetafectenePro (Biontex, Munich, Germany) as the transfection reagent. Transfected HEK293T cells were incubated for 48 h and fixed for 20 min in 2% paraformaldehyde dissolved in PBS. After the fixation step, cells were washed twice with PBS and carefully detached from the wells. The cell suspension was dropped on polyl-lysine coated slides (Thermo Scientific, Braunschweig, Germany) within a 2 cm 2 PAP-pen (Sigma Aldrich) encircled barrier. Cells were dried on glass slides, washed with PBS, and rinsed with 0.25% saponin (Carl Roth, Karlsruhe, Germany) for permeabilization. After 30 min, cells were blocked for 2 h at room temperature in 30% normal donkey serum (Jackson ImmunoResearch, West Grove, PA). BSA fraction V (Carl Roth) dissolved in PBS or Duolink II blocking solution (1×) was used to test blocking conditions.
In situ PLA application and FRET sample preparation
The blocked cells were incubated for FRET-PLA with primary antibodies (5 µg/mL) goat anti-FLAG (NB600-344, NovusBio, Littleton, CO) and mouse anti-V5 antibody (MCA1360, Serotec, Düsseldorf, Germany). To test protein expression, we used goat anti-FLAG or goat anti-V5 (NB600-380, NovusBio). To verify the selectivity of the PLA experiments, we used the antibodies mouse anti-FLAG (ab18230, Abcam, Cambridge, UK) and goat anti-V5, as well as mouse anti-a1 subunit Na + ,K + -ATPase (ab7671, Abcam) and goat anti-V5. All cells were incubated with primary antibodies overnight at 4°C. On the following day, the cells were washed twice briefly with Duolink II buffer A and left for 2 h in Duolink II buffer A with gentle shaking. After this ex tended washing step, the cells were blocked again with 30% normal donkey serum for 1 h at room temperature. After the blocking, all further steps were done according to the Duolink II manual. To confirm PPI, the PLA probe anti-mouse PLUS and the PLA probe anti-goat MINUS were used; for the protein expression control, the PLA probe anti-goat PLUS and the PLA probe anti-goat MINUS were used. After incubation for 1 h at 37°C, the slides were briefly washed twice and left with gentle shaking for 2 h in Duolink II buffer A. The slides were further processed for ligation and amplification according to the Duolink II manual. All PLA cell controls transfected with empty vectors pCMVTag2B/pcDNA4B-V5-His were treated in the same way as cells co-transfected with the vectors pCMV-CD63-YFP-FL AG /p c D N A-g p 41-CFP-V5. Fo r normalized FRET (NFRET) measurements, cells were mounted in glycerol containing 0.1% p-phenylenediamine (Sigma Aldrich). For all other applications, Duolink II mounting medium was used. PLA values were obtained from three independent rolling circle amplification (RCA) reactions and randomly selected images. The same samples were used to obtain NFRET values in combination with indicated controls. All Duolink II reagents were obtained from Eurogentec (Angers, France). For FRET acceptor photobleaching experiments, HEK293T cells were seeded in ibiTreat 8-well slides (IBIDI, Munich, Germany) and co-transfected with FRET vectors.
Indirect immunofluorescence staining
For immunofluorescence experiments, cells were blocked with 10% rabbit normal serum (Sigma Aldrich) diluted in PBS and then processed further as described in the "In situ PLA application and FRET sample preparation" section to test PLA selectivity. Na Confocal laser scanning microscopy (cLSM) and FRET analysis All images were acquired using a Zeiss LSM 780 confocal laser scanning inver ted microscope (Carl Zeiss, Oberkochen, Germany) and a 63× oil immersion objective. Images for NFRET analysis were obtained using multitrack channel mode instrument settings for CFP channel at 405 nm and detected emission peak at 475 nm/27 nm bandwidth, excitation for FRET channel at 405 nm, and detected emission peak at 527 nm/48 nm bandwidth. YFP signals were additionally detected in a single track with an excitation at 514 nm and detected emission peak at 527 nm/55 nm bandwidth. Donor and acceptor bleed-through coefficients were determined by acquiring images only from a donor or an acceptor, respectively. NFRET values (9) were calculated on a pixel-by-pixel basis using a macro from the Zeiss ZEN 2010 software. The technique for obtaining NFRET Vol. 57 | No. 4 | 2014 values was described in detail by others (10) . Fluorescence intensity profiles were obtained from the same software. Acceptor photobleaching FRET experiments were performed using PFA-fixed HEK293T co-transfected cells as previously described in the PLA section. Within each cell, we defined regions of interest (ROIs) in the bleached and unbleached cell regions, as well as in the background region. The images were acquired in multitrack channel mode for CFP (excited at 405 nm, detected at 463-508 nm, 1.2% laser power intensity) and YFP (excited at 514 nm, detected at 515-611 nm, 1.5% laser power intensity). The 514-nm laser line was set at 100% laser power intensity at bleaching time points and calculated FRET efficiency with the Zeiss ZEN FRET implemented software was used to obtain values for each ROI. PLA signals were detected with Zeiss ZEN smart setup instrument settings for Texas Red analog dye. PLA dots were counted with the ImageJ pixel counting plugin, and nuclei were counted with the ImageJ cell counter plugin. The results were used to calculate PLA dots per cell. Indirectly immunostained Na + ,K + -ATPase was detected using Zeiss ZEN smart setup settings for 594-nm dyes.
Western blot analysis
At 48 h posttransfection, cells were lysed in 100 µL 2× Laemmli buffer, chromosomal DNA was degraded with 25 U of benzonase (Novagen, San Diego, CA), proteins were reduced with 5 µL b-mercaptoethanol and separated by SDS-PAGE using TGX gels (BioRad, Munich, Germany), and then transferred onto an Immobilon-P PVDF membrane (Millipore, Schwalbach, Germany). Lysates of expressed CFP, YFP, and CFP-YFP proteins were diluted 1:10 in 2× Laemmli buffer. Proteins were probed with 0.5 µg/mL of rabbit anti-GFP (ab6556, Abcam), 1.0 µg/mL of mouse anti-a1 Na + ,K + -ATPase, and 1.0 µg/mL of mouse anti-b actin (AM00194PU-N, Acris, Herford, Germany. Primary antibodies were detected with 0.125 µg/mL of HRP-conjugated goat antirabbit IgG or anti-mouse IgG (DAKO, Hamburg, Germany) and visualized with Pierce ECL Western blotting substrate (Thermo Scientific, Bonn, Germany). Western blot images were acquired 
Results and discussion
We identified CD63 as an interaction partner of the HIV-1 transmembrane protein gp41 in a split-ubiquitin Y2H screen (Supplementary Figure S1 ) and used FRET-PLA to confirm the novel interaction between these two proteins. One of the most challenging aspects in PPI studies is confirmation of Y2H results by independent techniques. PL A allows labeling of interacting proteins by primar y antibodies raised in different species. The primary antibodies are detected by DNA-conjugated secondary antibodies specifically recognizing the corresponding species. The next step of PLA is based on the ligation of conjugated DNA when the epitopes are in close proximity. After successful ligation, the resulting DNA circle can be amplified by the highly processive f29 DNA polymerase (11, 12) . This RCA generates several hundred-fold more DNA circles that can be visualized by performing incubation with complementary fluorescently labeled oligonucleotide probes. When applying this method, the PPI is detected in situ with a fluorescence microscope as bright fluorescent dots (13,14) (Figure 1) . In contrast to PLA, FRET analysis is based on photon-free transfer of energy from a donor fluorophore to an acceptor fluorophore and only occurs when the donor is very close (<10 nm) to the acceptor. The efficiency of this energy transfer is proportional to the inverse sixth power of the distance between the donor and acceptor (15) (16) (17) . We established the FRE T-PL A technique using FL AG/ V5 epitopetagg e d f luore sc e nt prote ins by combining standard PLA and FRET measurements in transiently transfected cells. PL A can detect PPIs involving endogenously (18) (19) (20) or transiently (21) expressed proteins. Our PLA test results were positive for CD63 and gp41 proteins expressed without a fluorescent protein tag (Figure 2A) . Introduction of fluorescent proteins in standard PLA analyses allows identification of cells expressing interactors, REPORTS and the PPI can be measured simultaneously by PLA and FRET analysis. For FRET quantification, the measurement of NFRET values was used to subtract donor or acceptor signal contaminations from the FRET image. The NFRET values are advantageous because of their independence from protein expression levels, allowing for better comparison between different samples in conjunction with whole-cell FRET measurements (9) .
For the correlative FRE T-PL A technique, we used the recombinant proteins gp41 and human CD63, tagged with CFP and YFP respectively. In the donor protein gp41-CFP-V5, a signal sequence from Ig kappa-chain V-J2-C (SP1) was introduced to the N terminus to increase the level of protein expression (22) in transfected HEK293T cells (Supplementary Figure S2) . V5 and FLAG tags were used to detect the fluorescent hybrid proteins by PLA. Establishing correlative FRET-PL A requires that the fluorescent tags do not interact with themselves. To avoid this effect, we used modified SCFP3A and SYFP2 templates to improve the brightness and monomeric properties of the expressed fluorescent proteins (7), which for simplicity were called YFP and CFP.
We carried out the FRE T-PL A technique on an HEK293T cell-based system and prepared the samples in accordance with the FRET-PL A workflow diagram (Supplementar y Figure S3 ). The intensity plots showed that PLA signals were not produced in the absence of CFP or YFP, and the detection of positive PLA signals was possible only when CFP and YFP intensities were measured within the same distance ( Figure 2B ). The feasibility of correlative FRET-PLA is further supported by the observation that FRET analysis revealed high NFRET values where PLA signals occurred. Consequently, cells expressing FRET protein pairs yielded PLA signals and, most importantly, the amount of PLA signals strongly correlated with the NFRET value ( Figure 2C ). The lack of significant PLA signals in controls indicated a true PPI between the acceptor protein CD63-YFP-FLAG and the donor protein gp41-CFP-V5.
We characterize the correlation for each PLA intensity profile by calculating the Pearson´s correlation coefficient (r) between FRET←→PLA and CFP←→YFP. The results consistently showed a strong positive correlation between PL A and FRET signals (r = 0.62 ± 0.29); however, between CFP and YFP signals (r = 0.15 ± 0.40) the correlation coefficient varied from no correlation to a weak-strong negative and positive correlation ( Figure 2D) . Furthermore, the sequential quantification of cells expressing CFP, cells expressing YFP, and the whole-cell population clearly showed that the PLA signals are not evenly distributed across all cell populations ( Figure 2E i) .
To separately showed low values of NFRET and are considered negative FRET controls. When CD63-YFP-FLAG and gp41-CFP-V5 were coexpressed, high NFRET values were measured ( Figure 2E ii). We can obviously exclude the possibility that fused fluorescent prote ins c ould induc e nons p ecific dimerization because unfused CD63-FL AG and gp41-V5 proteins also showed PLA signals (Figure 2A) .
In addition to intensity-based FRET measurement, we also obtained FRET interaction data using acceptor photobleaching. This method is based on acceptor depletion and continuous monitoring of donor and acceptor fluorescence intensities (I) during the acceptor photobleaching process (23) . We examined the fluorescence intensity profiles of the FRET bleaching experiments ( Figure 3A ) and observed that for the FRET pair CD63-YFP-FLAG/ gp41-CFP-V5, CFP intensity increased af ter acceptor photobleaching at several time points ( Figure 3B ) and was reproducible over a set of 12 cells. Photobleaching experiments were used to calculate FRET efficiencies, which also confirmed a PPI between CD63-YFP-FLAG and gp41-CFP-V5, and are clearly dif ferent from the pseudo-FRET efficiencies obtained from separately expressed CFP and YFP ( Figure 3C) .
A highly relevant quality criterion of PLA experiments is the ability to deliver reliable signals that are free from interference. To meet this requirement, we validated our correlative FRET-PLA and investigated the specificity and selectivity of the PLA detection. A highly sensitive method such as PLA, based on epitope recognition in combination with increased signals produced by RCA, will always be associated with nonspecific signals. We considered several factors to reduce nonspecific PLA signals. These included a shorter incubation time for antibodies and PLA probes, a shorter RCA time, increased washing stringency, and variations of blocking conditions. The only factor that remained was to find an optimized blocking condition. We performed different blocking experiments and found that an extended blocking step using 30% normal donkey serum combined with an extended washing time was the most effective strategy for reducing unspecific PLA signals ( Figure 4A ). Under these blocking conditions, a single detected PLA dot is more than 93% ± 3% reliable for specific epitope recognition ( Figure 4B ) and proves the specificity of the primary antibodies used. It was previously shown that the PLA and FRET performance can be compared in a semiquantitative manner (24) . The reported saturation phenomenon in PLA applications representing nonlinearities in high protein concentrations using 1% BSA was observed by FACS analysis of PLA signals. As we showed in our specificity assay (Figure 4A ), the blocking condition is a major issue in PLA experiments. We suggest that linearity can be reached by optimized blocking conditions, as we show that the blocking conditions are very important to obtain highly specific PLA results.
To evaluate expression of the acceptor and donor proteins, a single recognition PLA was performed using one polyclonal antibody to detect only FL AG or V5 tag. For single recognition PLA, we observed high numbers of positive PL A dots for FLAG or V5 recognition in contrast to the control consisting of HEK293T cells transfected with empty vectors ( Figure 4C, Supplementary Figure S4) . We additionally characterized the expre ssed proteins by We stern blot analysis and showed that all fluorescent proteins are expressed ( Figure 4D ). To account for nonspecific antibody binding and for false-positive PL A detection on the cell surface, proteins localized in the nucleus were investigated. For this, an exogenous zinc finger nuclease (ZFN)-YFP fusion protein tagged with a FLAG epitope was used. This control experiment showed the absence of nonspecific antibody binding to the cell surface and the presence of specific binding to the target in the nucleus ( Figure 4E and Supplementary Figure S5) .
To provide more direct evidence that PL A is comparable with FRET analysis, we next focused on determining the selectivity of the PL A. We used the endogenous Na + ,K + -ATPase as a reference because of its similarity to CD63. We showed by indirect immunostaining that these two proteins were predominantly expressed in the plasma membrane ( Figure 4F ) and ruled out by Western blot analysis the possibility that in the experiments PLA 1 and PLA 2, protein expression of Na + ,K + -ATPase is reduced ( Figure 4H ). The key in our validation assays is the application of a primary antibody (clone 464.6, also known as 6H) raised against amino acids 1-21 of Na + ,K + -ATPase (25,26) that detects epitopes in the intracellular part of the molecule in the PLA experiments. Our PLA results showed that gp41-CFP-V5 is not able to reach close proximit y with the Na + ,K + -ATPase, although we proved that the primary antibodies are able to detect Na + ,K + -ATPase ( Figure 4G , Figure 4I ). These results suggest that PLA can be used to study specific PPIs in a pool of proteins expressed within the same cellular compartment. ,K + -ATPase is Triton-insoluble, which leads to the conclusion that it is associated with lipid rafts (26) (27) (28) . Membranes also contain a particular type of microdomain distinct from conventional lipid rafts called tetraspanin-enriched m i c ro d o m a i n s ( T EM s). Prote i n s associated within TEMs can be solubilized independently from lipid microdomains, although they were found to associate with microdomains resembling lipid rafts (29) . Tetraspanins such as CD63 act as molecular organizers of membrane protein complexes in the TEM. We propose that the lack of PLA signal between CD63 and Na + ,K + -ATPase is due to their organization into different membrane microdomains and indicates that we only detect PPIs by PLA when interactors are in very close proximity.
In summary, our results provide evidence that PLA signals correlate strongly with FRE T signals. The advantage of our method is that the combined application of FRET and PLA can be used to detect protein interactions in conditions of weak protein expression levels or low transfection efficiencies. Another benefit is that correlative FRET-PLA analysis takes much less time to obtain results by two independent methods. The difficulty of identifying and measuring direct PPIs between membrane proteins is one of the reasons why the development of various interaction techniques has remained in focus in the past decades. Considering that more that 60% of approved drugs are targeted at membrane proteins (30) , it is clear that these proteins play an important role in biological processes. We believe that correlative FRET-PLA can provide a more precise characterization of PPI and will be useful in the investigation of molecular interactions between membrane proteins.
Author contributions D.I. designed and performed the experiments, and analyzed the data. The manuscript was written by D.I., M.E., and J.D. All authors read and approved the manuscript.
Keeping a watchful eye on cytosolic DNA.
Innate immune detection of intracellular DNA derived from viruses and invasive bacteria is very important to initiate an effective protective response. This crucial step depends on cytosolic DNA sensors (CDSs), which upon activation, trigger the production of type I interferons (IFNs) and the induction of IFNresponsive genes and proinflammatory chemokines. InvivoGen has developed innovative tools in order to facilitate the study of CDS. 
An expanding range of tools
